silybin has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chun, HJ; Jung, YS; Lee, J; Lee, KM; Lee, Y | 1 |
| Fu, J; Fujisaki, H; Hattori, S; Hayashi, T; Ikejima, T; Liu, W; Liu, X; Mizuno, K; Song, S; Wang, C | 1 |
| Chen, Y; Fujisaki, H; Hattori, S; Hayashi, T; Ikejima, T; Liu, P; Liu, W; Liu, X; Mizuno, K; Wang, C | 1 |
| Chen, W; Fujisaki, H; Hattori, S; Hayashi, T; Ikejima, T; Liu, W; Liu, X; Mizuno, K; Wang, C | 1 |
4 other study(ies) available for silybin and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Silibinin suppresses astroglial activation in a mouse model of acute Parkinson's disease by modulating the ERK and JNK signaling pathways.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Animals, Newborn; Antioxidants; Astrocytes; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Enzyme Inhibitors; Glial Fibrillary Acidic Protein; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Rats, Sprague-Dawley; Silybin; Silymarin; Time Factors; Tyrosine 3-Monooxygenase | 2015 |
Oral Administration of Silibinin Ameliorates Cognitive Deficits of Parkinson's Disease Mouse Model by Restoring Mitochondrial Disorders in Hippocampus.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Oral; alpha-Synuclein; Animals; Apoptosis; Cerebral Cortex; Cognitive Dysfunction; Hippocampus; Male; Memantine; Mice, Inbred C57BL; Mitochondria; Mitochondrial Diseases; Morris Water Maze Test; Neurons; Neuroprotective Agents; Open Field Test; Oxidative Stress; Parkinsonian Disorders; Silybin | 2021 |
Silibinin attenuates motor dysfunction in a mouse model of Parkinson's disease by suppression of oxidative stress and neuroinflammation along with promotion of mitophagy.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopaminergic Neurons; Mice; Mice, Inbred C57BL; Mitophagy; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Silybin; Substantia Nigra | 2021 |
Silibinin ameliorates depression/anxiety-like behaviors of Parkinson's disease mouse model and is associated with attenuated STING-IRF3-IFN-β pathway activation and neuroinflammation.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anxiety; Depression; Disease Models, Animal; Humans; Interferon Regulatory Factor-3; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Parkinson Disease; Quality of Life; Silybin | 2021 |